George Clinical – Page 3 – George Clinical

George Medicines Initiates Two Phase III Trials of Triple Combination Candidate to Treat Hypertension

George Medicines, a late-stage drug development company focused on providing innovative and accessible medicines for the world’s leading causes of death and a sister company to George Clinical, has initiated two Phase III trials investigating its proprietary triple combination candidate, GMRx2, as a first-line treatment for hypertension. Recent hypertension guidelines recommend combination therapy as initial […]

July 16th, 2021

Scientific Leadership Highlighted During 2021 ASCO

George Clinical’s deep oncology research expertise was on display during the 2021 ASCO Annual Meeting. Several leaders were featured in sessions during the conference including Drs. Lee Schwartzberg, Ari VanderWalde, Herbert Loong, Ralph Boccia, Timothy Pluard and Jason Chandler. Schwartzberg is a co-author on 10 different abstracts that were highlighted in sessions during the virtual event […]

June 24th, 2021

George Medicines Appoints Stefan König as Chief Executive Officer

Sister organization George Medicines, a late-stage drug development company focused on providing innovative and accessible medicines for the world’s leading causes of death, announced the appointment of Stefan König as Chief Executive Officer. George Medicines, a venture-backed spin-out company from The George Institute for Global Health, one of the world’s leading independent medical research institutes, […]

June 17th, 2021

George Clinical and Omico Align to Evolve Oncology Study Enrollment Through Genomic Profiling in Australia

SYDNEY, June 15, 2021 – George Clinical, a global scientifically-backed clinical research organization, and Omico, an Australian-based not-for-profit national precision oncology platform, have aligned to revolutionize oncology clinical trial access for patients and improve the efficiency of study enrollment. The two organizations began collaborating in late 2020 and announced the joint effort during the 2021 […]

June 15th, 2021

George Clinical Celebrates our Global Team Members on Clinical Trials Day

The important achievements of clinical research around the world hold the potential to improve the health and wellness of humanity. Both leading projects day to day as well going the extra mile behind the scenes stand more than 300 of our dedicated, professional project team members across 38 geographical locations throughout the USA, Asia-Pacific region and […]

May 21st, 2021

DARE-19 Phase III Collaboration between AstraZeneca, Saint Luke’s Mid America Heart Institute and George Clinical Shows Treatment’s Well-Established Safety Profile Was Consistent in Patients with COVID-19

Detailed results from the primary analysis of the DARE-19 Phase III trial assessing the potential of Farxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, to treat patients hospitalized with COVID-19 who are at risk of developing serious complications showed that the trial did not achieve statistical significance for the two primary endpoints. However, there were […]

May 19th, 2021

Link Health and George Clinical Create New Mode of Pharmaceutical Research and Development in China

BEIJING and SYDNEY, April 29, 2021 – Guangzhou Link Health Pharma Co., Ltd. (Link Health) and George Clinical Pty Ltd (George Clinical) have signed a term sheet to enter into a strategic agreement to establish an independent joint venture clinical development company called Link-George Clinical Research Co., Ltd (Link-George). Link-George will deliver clinical trials for […]

April 30th, 2021

Scientific Leader Adrian Liew Wins the ISPD John Maher Award

Dr. Adrian Liew, a nephrologist and scientific leader with George Clinical, was the recipient of the 2020 International Society for Peritoneal Dialysis Congress John Maher Award, honoring young individuals who have contributed substantially to the field of peritoneal dialysis (PD). Maher was a great contributor to the advancement of hemodialysis and peritoneal dialysis. He directed […]

April 2nd, 2021

Rheumatology Clinical Researcher Professor David Hunter Joins George Clinical Scientific Leadership

OVERLAND PARK, Ks., February 23, 2021 – David Hunter, MBBS, PhD, a renowned clinical researcher and rheumatology expert based in Australia, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research organization. Professor Hunter’s research focus is clinical and translational research in osteoarthritis (OA). He is the Florance and Cope Chair of […]

February 22nd, 2021

A Message from Our CEO Regarding COVID-19

The COVID-19 pandemic continues to bring challenges to all of us on personal and professional levels but the importance of clinical research has perhaps never been higher. Our priority at George Clinical continues to be the safety and wellbeing of our employees, patients, investigators, clients and partners as we continue to execute critical studies in […]

February 21st, 2021